During the 4th neurosurgery conference in Hospital 57357: Presenting the Hospital’s leading experience in neurosurgery

Recording 15000 neurosurgeries since its inception and big progress in critical brain surgeriesStarting a specialized diploma in cooperation with Alabama University
Yesterday, March 2, 2023, was the start of the 4th neurosurgery conference which was hosted and organized by Hospital 57357 in cooperation with the African Pediatric Neurosurgical oncology society, APNOS, to discuss the latest advancements and research studies in pediatric neurosurgery.
The conference was held in the Hospital’s auditorium during the period from 2nd to 4th of March, under the patronage of Dr. Mohamed Ayman Ashour, the minister of high education and research and in cooperation with Alkasr Al-Aini medicine school, Cairo University, the Egyptian Society of Neurosurgeons, the International Society of Pediatric Neurosurgeons and the International Society of pediatric Neurosurgery (ISPN). The conference was attended by neurosurgery experts from USA, Europe, the Middle East and Africa.
Dr. Sherif Abouel Naga, the Hospital’s general manager, highlighted the role of the neurosurgery department in progressing with precise and complicated surgeries to save children’s lives, and the Hospital’s commitment to its mission of offering treatment and cure to children for free, despite the difficult economic conditions surrounding the Hospital and prevailing around the world. He asserted that the Hospital is involved in serious research work and concerned about putting theories into application. He thanked the professors of Dana Farber Institute, Harvard University, Boston (Dr. Mark Keran, Dr. Lesly Lehman, and Dr. Lilian Geominrova), for their efforts in supporting 57357’s through the common fellowship program that aim to improve pediatric oncologists’ qualifications and training them on latest treatment methods. He praised Alkasr Al-Aini’s neurosurgery department and presented the Hospital’s most important developmental projects namely the launching of the cyberknife unit. He announced the imminent completion of the proton therapy project. Both projects do not just aim to improve treatment results but to also enable sources of income to support our children’s treatment as their services will be available to treat adults from outside the Hospital against a revenue that will contribute to treating the children.
57357’s experience
Dr. Mohamed Albeltagy, head of the conference and head of Hospital 57357’s neurosurgery department, revealed that the conference is a chance for expertise exchange and a showcase for Hospital 57357’s experience in the neurosurgery field and its achievements in precise complicated neurosurgeries such as in the case of craniopharyngioma (considered the most difficult brain tumor for its critical location close to vital centers), in base of skull tumors, some types of pituitary tumors and complicated brain tumors for children aged one year. He mentioned that Hospital’s experts have performed more than 15 thousand neurosurgeries since its opening, 12 thousands of which are complicated, with overall five year survival rate and an average success rate of 88%, with a specific success rate of 98% in benign cases and 75% in malignant cases. Among the important lectures in the conference, was the one about treatment resistant tumor associated epilepsy.
Alabama University diploma
An imminent diploma in cooperation with Alabama University was announced that will tackle methods of monitoring nerves during brain and vertebral column surgeries. On the sideline of the conference, a number of lectures and workshops around brain endoscopes and using sonar to monitor nerves during the surgery, were held, where 57357 is a leader in using the nerves monitoring device during spinal cord surgeries for children.
Latest research studies
About the causes of brain tumors, Dr. Albeltagy revealed that different types of pollution such as radioactive contamination and chemical pollution, or weakness of the immunity system would trigger the growth of cancer cells. Its symptoms usually include headache, repeated morning vomiting which is resistant to medication, changes in behavior and aggressiveness